Alpha 2.0

» Articles » PMID: 38525315

Comparative Analysis of Three Atherosclerotic Cardiovascular Disease Risk Prediction Models in Individuals Aged 75 and Older

Overview

Overview

Journal Clin Interv Aging

Publisher Dove Medical Press

Specialty Geriatrics

Date 2024 Mar 25

PMID 38525315

Authors

Authors

Zhang Wang

Xue Yang

Longxin Li

Xiaobo Zhang

Wenlin Zhou

Sixue Chen

Affiliations

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the performance of the Framingham cardiovascular risk score (FRS)/pooled cohort equations (PCE)/China prediction for atherosclerotic cardiovascular disease (ASCVD) risk (China-PAR model) in a prospective cohort of Chinese older adults.

Patients And Methods: We assessed 717 older adults aged 75-85 years without ASCVD at the baseline from the Sichuan province of China. The participants were followed annually from 2011 to 2021. We obtained the participants' information through the medical records of physical examination and evaluated their 10-year ASCVD risk using FRS, PCE, and China-PAR. We further evaluated the predictive abilities of three assessment models.

Results: During the 10-year follow-up, 206 participants developed ASCVD, with an incidence rate of 28.73%. The FRS and China-PAR moderately underestimated the risk of ASCVD (22.1% and 12.4%, respectively), but while PCE overestimated the risk (36.1%). FRS and China-PAR were found to underestimate the risk of ASCVD (26% and 63%, respectively) for men, while PCE overestimated the risk by 8%; For women, FRS and China-PAR were found to underestimate the risk of ASCVD (14% and 35%, respectively), while PCE overestimated the risk by 88%.

Conclusion: The 10-year ASCVD risk was found to be overestimated by PCE. China-PAR had the most accurate predictions in women, while FRS was particularly well-calibrated in males. All three risk models have good discrimination, with FRS and PCE being well-calibrated in men and all three being well-calibrated in women. Therefore, accurate risk models are warranted to facilitate the prevention of ASCVD at the baseline among Chinese older adults.

References

1.

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

2.

Pylypchuk R, Wells S, Kerr A, Poppe K, Riddell T, Harwood M . Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study. Lancet. 2018; 391(10133):1897-1907. DOI: 10.1016/S0140-6736(18)30664-0. View

3.

Fang E, Xie C, Schenkel J, Wu C, Long Q, Cui H . A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks. Ageing Res Rev. 2020; 64:101174. PMC: 7505078. DOI: 10.1016/j.arr.2020.101174. View

4.

Komamura K, Fukui M, Iwasaku T, Hirotani S, Masuyama T . Takotsubo cardiomyopathy: Pathophysiology, diagnosis and treatment. World J Cardiol. 2014; 6(7):602-9. PMC: 4110608. DOI: 10.4330/wjc.v6.i7.602. View

5.

Goff Jr D, Lloyd-Jones D, Bennett G, Coady S, DAgostino R, Gibbons R . 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 129(25 Suppl 2):S49-73. DOI: 10.1161/01.cir.0000437741.48606.98. View

6.

ODonnell M, Chin S, Rangarajan S, Xavier D, Liu L, Zhang H . Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016; 388(10046):761-75. DOI: 10.1016/S0140-6736(16)30506-2. View

7.

Yang X, Li J, Hu D, Chen J, Li Y, Huang J . Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China). Circulation. 2016; 134(19):1430-1440. DOI: 10.1161/CIRCULATIONAHA.116.022367. View

8.

Arnett D, Blumenthal R, Albert M, Buroker A, Goldberger Z, Hahn E . 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140(11):e563-e595. PMC: 8351755. DOI: 10.1161/CIR.0000000000000677. View

9.

Luo Y, Su B, Zheng X . Trends and Challenges for Population and Health During Population Aging - China, 2015-2050. China CDC Wkly. 2021; 3(28):593-598. PMC: 8393078. DOI: 10.46234/ccdcw2021.158. View

10.

Filion K, Luepker R . Cigarette smoking and cardiovascular disease: lessons from framingham. Glob Heart. 2015; 8(1):35-41. DOI: 10.1016/j.gheart.2012.12.005. View

11.

Hung J, Knuiman M, Divitini M, Davis T, Beilby J . Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. Am J Cardiol. 2008; 101(2):193-8. DOI: 10.1016/j.amjcard.2007.07.061. View

12.

Chen Z, Peto R, Zhou M, Iona A, Smith M, Yang L . Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet. 2015; 386(10002):1447-56. PMC: 4691901. DOI: 10.1016/S0140-6736(15)00340-2. View

13.

Liu S, Li Y, Zeng X, Wang H, Yin P, Wang L . Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study. JAMA Cardiol. 2019; 4(4):342-352. PMC: 6484795. DOI: 10.1001/jamacardio.2019.0295. View

14.

Rich M, Chyun D, Skolnick A, Alexander K, Forman D, Kitzman D . Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society. Circulation. 2016; 133(21):2103-22. DOI: 10.1161/CIR.0000000000000380. View

15.

Lerner D, Kannel W . Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986; 111(2):383-90. DOI: 10.1016/0002-8703(86)90155-9. View

16.

Alpert J, Thygesen K, Antman E, Bassand J . Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000; 36(3):959-69. DOI: 10.1016/s0735-1097(00)00804-4. View

17.

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2019; 43(Suppl 1):S14-S31. DOI: 10.2337/dc20-S002. View

18.

Tang X, Zhang D, He L, Wu N, Si Y, Cao Y . Performance of atherosclerotic cardiovascular risk prediction models in a rural Northern Chinese population: Results from the Fangshan Cohort Study. Am Heart J. 2019; 211:34-44. DOI: 10.1016/j.ahj.2019.01.009. View

19.

DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

20.

Rana J, Tabada G, Solomon M, Lo J, Jaffe M, Sung S . Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. J Am Coll Cardiol. 2016; 67(18):2118-2130. PMC: 5097466. DOI: 10.1016/j.jacc.2016.02.055. View